[8] Steele ML, Fuller S, Maczurek AE, Kersaitis C, Ooi L, Mnch G
For instance, in the DURATION-8 trial [36], once-weekly exenatide in combination with once-daily dapagliflozin did not lead to major hypoglycemia episodes over 104 weeks of treatment, with few events of minor hypoglycemia (1.7%)
Semaglutide is a medication that is currently used to treat type 2 diabetes, but recent studies have shown that it may also be effective for weight loss
Extensive clinical trials conducted during the drug's development, including the SUSTAIN programme, involved thousands of patients with type 2 diabetes followed over several years
Combination Therapy: The combination of glutathione and Vitamin C, Alpha Lipoic Acid or Collagen Boosters incurs a higher cost of treatment
But they lack the extensive clinical trial data and FDA oversight of brand medications